Cargando…
Controversies regarding lithium-associated weight gain: case–control study of real-world drug safety data
BACKGROUND: The impact of long-term lithium treatment on weight gain has been a controversial topic with conflicting evidence. We aim to assess reporting of weight gain associated with lithium and other mood stabilizers compared to lamotrigine which is considered free of metabolic adverse drug react...
Autores principales: | Greil, Waldemar, de Bardeci, Mateo, Müller-Oerlinghausen, Bruno, Nievergelt, Nadja, Stassen, Hans, Hasler, Gregor, Erfurth, Andreas, Cattapan, Katja, Rüther, Eckart, Seifert, Johanna, Toto, Sermin, Bleich, Stefan, Schoretsanitis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577117/ https://www.ncbi.nlm.nih.gov/pubmed/37840048 http://dx.doi.org/10.1186/s40345-023-00313-8 |
Ejemplares similares
-
Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data
por: de Bardeci, Mateo, et al.
Publicado: (2022) -
Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project
por: Stübner, Susanne, et al.
Publicado: (2018) -
Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017
por: Seifert, Johanna, et al.
Publicado: (2021) -
Cardiovascular Adverse Reactions During Antidepressant Treatment: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2010
por: Spindelegger, Christoph Josef, et al.
Publicado: (2015) -
Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001–2017
por: Seifert, Johanna, et al.
Publicado: (2022)